Important Updates on COVID-19

As the COVID-19 (coronavirus) pandemic continues to evolve around the world, Otsuka stands united with our global community to navigate this fast moving and complex healthcare event.

Read the full statement
As the COVID-19 (coronavirus) pandemic continues to evolve around the world, Otsuka stands united with our global community to navigate this fast moving and complex healthcare event. We are taking every appropriate action to safeguard our employees and families as well as those who provide services to Otsuka as contractors. Equally as important is the safety and welfare of the patients and caregivers we serve as well as the healthcare professionals who are on the front lines providing critical care to those in need. To that end, we are pleased to announce that as of April 10, 2020, we have extended our patient support program to provide “no-cost” access to our branded portfolio of prescription medicines for patients in the U.S. who have lost a job or health insurance coverage due to the COVID-19 (coronavirus) pandemic. Patients, their caregivers, and their prescribing team, can access tools, resources, and our dedicated team of support members for more information: Website: www.OtsukaPatientSupport.com Under Abilify Maintena, there are two tools: Local Care Center (LCC) Finder and Integrated Pharmacy Network (IPN) Finder tools
  • For Abilify Maintena, both LCC and IPN specialize in treating patients with SMI
 In-house call center: 1-855-242-7787 (M-F, 8am-8pm EDT) Otsuka Patient Support Center nurses, with both mental health and nephrology experience,  can answer questions related to Product Accessibility, Reimbursement and even connecting patients to local treatment sites in their community. Click the links below to view letters from our CEO to customers and patients.  Letter to Customers  Letter to Patients